Who won the 1 billion yuan gamble of GREE and millet?

Everything is expected, millet finally submitted to the Hong Kong exchange to submit a listing application, from 2010 to the present, only 8 years, the Lei Jun has created a miracle, the listed millet at least 10 billion dollars to raise funds, millet market value is also expected to hit a 100 billion dollar mark.
Need the help of loan calculator and balance transfer service to pay off card debt? CCB(Asia) has special offers for you, apply for personal loans online and enjoy cash coupon and cash rebates now!

Victoria Dockside is a new global art and design district located in the historical landmark,Culture and Craftsmanship which aimed to push a new frontiers in different segments.
It is also a coincidence, this year is just the last year of the millet thunder army and GREE Dong Mingzhu 1 billion yuan gambling, in 2013 two people on the CCTV gambling, said that 5 years after 5 years to see whose revenue, originally 1 Yuan Lei Jun, Dong Mingzhu called 1 billion, 2018 will be the answer to the first year, we first look at the results of 2017, grid. The revenue of last year was 150 billion yuan, and Millet's revenue in 2017 increased to 114 billion 600 million yuan. From the growth momentum, in 2018, millet still has a large increase in possibility, but the possibility of double growth is indeed a little unrealistic. GREE also fought well, even shouting the target of 200 billion yuan in revenue. So judging from the results, it is rather difficult for millet to beat GREE in revenue in 2018. But the thunder army is not care, all this is not important, because if the millet is successfully listed in the market value of 100 billion dollars, then millet and GREE is no longer a heavyweight, millet will more than double GREE more than twice. So in fact, we said early that GREE won the gambling, but millet won the future, because the two companies are not the same time, GREE is an industrial product high-end manufacturing company, and millet is an apple in China's practitioner, he is a high-tech company. So the outlook of the two companies is quite different, and the valuation in the capital market is also very different.Clinicians should keep an eye on this patient population opiates for anxiety.